The Relation Between Diabetic Neuropathy and Muscle Mass in Type 2 Diabetes Mellitus Patients

Launched by AIN SHAMS UNIVERSITY · Apr 26, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how diabetic neuropathy, a condition that affects the nerves in people with diabetes, is related to muscle mass in patients with type 2 diabetes. The study aims to understand if there is a connection between having nerve damage and losing muscle strength or mass. It is currently recruiting participants who are at least 45 years old and have been diagnosed with type 2 diabetes.

To join the study, participants should not have type 1 diabetes or certain other medical conditions, such as severe lung or heart issues, past significant neurological disorders, or kidney diseases. During the trial, participants will undergo evaluations to measure their muscle mass and assess any nerve damage. This research could help improve care for people with diabetes by highlighting the importance of muscle health in managing the condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The study group consisted of patients diagnosed with Type 2 diabetes mellitus aged ≥45 years old
• Exclusion Criteria:
• • Type 1 DM, gestational diabetes mellitus
• • Severe cardiopulmonary disease, significant/previous neurological disorder (e.g., ischemic stroke, Parkinson disease) causing difficulty during daily activities (e.g., walking), visual deficit, and psychiatric problem
• • Other neuropathy-associated factors such as: alcohol, nutrition, poisoning and drug addiction
• • Patients with renal diseases, malignancy and autoimmune diseases
• • Patients on long term use of Steroids